Rosiglitazone Reduces Glucose-Induced Oxidative Stress Mediated by NAD(P)H Oxidase via AMPK-Dependent Mechanism

Abstract

Objective-Hyperglycemia is the main determinant of long-term diabetic complications, mainly through induction of oxidative stress. NAD(P)H oxidase is a major source of glucose-induced oxidative stress. In this study, we tested the hypothesis that rosiglitazone (RSG) is able to quench oxidative stress initiated by high glucose through prevention of NAD(P)H oxidase activation. Methods and Results-Intracellular ROS were measured using the fluoroprobe TEMPO-9-AC in HUVECs exposed to control (5 mmol/L) and moderately high (10 mmol/L) glucose concentrations. NAD(P)H oxidase and AMPK activities were determined by Western blot. We found that 10 mmol/L glucose increased significantly ROS production in comparison with 5 mmol/L glucose, and that this effect was completely abolished by RSG. Interestingly, inhibition of AMPK, but not PPAR␥, prevented this effect of RSG. AMPK phosphorylation by RSG was necessary for its ability to hamper NAD(P)H oxidase activation, which was indispensable for glucose-induced oxidative stress. Downstream of AMPK activation, RSG exerts antioxidative effects by inhibiting PKC. Conclusions-This study demonstrates that RSG activates AMPK which, in turn, prevents hyperactivity of NAD(P)H oxidase induced by high glucose, possibly through PKC inhibition. Therefore, RSG protects endothelial cells against glucose-induced oxidative stress with an AMPK-dependent and a PPAR␥-independent mechanism. (Arterioscler

AMP-dependent Kinase Inhibits Oxidative Stress-induced Caveolin-1 Phosphorylation and Endocytosis by Suppressing the Dissociation between c-Abl and Prdx1 Proteins in Endothelial Cells

“…However, the precise mechanism by which AMPK protects the endothelium from oxidative stress remains unclear. Ceolotto et al (41) reported that AMPK protects HUVEC against glucose-induced oxidative stress by suppressing hyperactivity of NAD(P)H oxidase. Deng et al (42) reported that AMPK protects human aortic endothelium by increasing NO production via endothelial NOS phosphorylation.…”

L’AMPK, régulateur de l’énergie et des fonctions des spermatozoïdes

“…Ces auteurs ont rapporté une réduction significative de la capacité de ces animaux à féconder en raison d'une asthénozoospermie (défaut de mobilité) et d'un taux important d'anomalies morphologiques (fragilité membranaire de la tête, anomalies des mitochondries) des spermatozoïdes. Toutefois, aucune altération de la morphologie des testicules ou de la production de sperme n'a la réactivation de la kinase pourrait ainsi contrecarrer les effets négatifs du stress oxydatif lié à cette maladie métabolique [35]. Dans un modèle murin de diabète de type II, un activateur de l'AMPK, le resvératrol, permet en effet de diminuer la production d'anion superoxyde et la carbonylation 7 des protéines par un mécanisme qui dépend de la kinase [36].…”

The PPARγ Agonist Protects Cardiomyocytes from Oxidative Stress and ApoptosisviaThioredoxin Overexpression

“…19) RSG also protects endothelial cells from glucose-induced oxidative stress through an AMPActivated Protein Kinase-dependent molecular pathway. 20) In addition, PPAR agonist reduces the fraction of neonatal rat CMCs (rCMCs) that undergo apoptosis under oxidative stress, through upregulation of Bcl-2 expression. 21) Given this background, we hypothesized that PPAR agonist RSG can reduce the apoptosis of rCMCs in the oxidative state created by H 2 O 2 , and that this protective action results from TRx overexpression.…”